Regulation of mitochondrial function by folate enzyme ALDH1L2 in health and disease

叶酸酶 ALDH1L2 在健康和疾病中对线粒体功能的调节

基本信息

  • 批准号:
    10372093
  • 负责人:
  • 金额:
    $ 47.58万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2019
  • 资助国家:
    美国
  • 起止时间:
    2019-04-01 至 2024-03-31
  • 项目状态:
    已结题

项目摘要

The physiological role of the mitochondrial folate enzyme ALDH1L2, discovered by the PI's lab in 2010, is not well understood. This enzyme catalyzes the reaction: NADP+ + 10-formyltetrahydrofolate → NADPH + CO2 + tetrahydrofolate, which can be important for the mitochondrial NADPH production from the oxidation of folate- bound one-carbon groups. In support of this function, our recent gene knockout experiments show that deletion of Aldh1l2 in mice causes increased oxidative stress. Furthermore, Aldh1l2-/- mice develop ulcerative dermatitis, and have highly enlarged (4-fold) spleen and extensively altered metabotype. The mechanistic basis underlying these phenotypes is currently unknown but has clinical relevance given the recent identification of patients with ALDH1L2 mutations who were diagnosed with a rare neurocutaneous disease or autistic spectrum disorder. Our metabolomics analysis of patient's fibroblasts identified dramatic changes in the cellular lipid repertoire, the outcome most likely caused by the impairment of mitochondrial CoA-dependent fatty acid metabolism. This leads to mitochondrial dysfunction, which is manifested as insufficient energy production and oxidative stress. In further support of this mechanism, fibroblasts from ALDH1L2-deficient patients have fragmented mitochondria and show the accumulation of lipid droplets. Importantly, the restoration of the ALDH1L2 enzyme in these fibroblasts rescues the phenotype and metabotype, making these cells similar to fibroblasts from healthy individuals. Based on these findings, we hypothesize that ALDH1L2 serves distinct metabolic function in the cell, the maintenance of redox state through the mitochondrial NADPH generation linked to the folate cycle. The loss of ALDH1L2 leads to mitochondrial dysfunction, energy disbalance and oxidative stress. Thus, deleterious mutations in the ALDH1L2 gene are underlying cause of mitochondria-related human disorders/diseases. This proposal will determine the role of ALDH1L2 in cellular metabolism and will link its mutations as causative factor of human diseases through the following aims: (1) Test the hypothesis that ALDH1L2 maintains mitochondrial redox balance and controls coenzyme A biosynthesis and fatty acid oxidation. (2) Define the role of ALDH1L2 in partitioning of one-carbon groups between energy production or mitochondria to cytoplasm shuttling. (3) Establish ALDH1L2 deficiency as the cause of rare genetic disorders in humans and explore underlying mechanisms. It is now clear that mitochondrial dysfunction is an important component in the pathophysiology of numerous diseases that had not been previously identified. The role of ALDH1L2 in maintenance of mitochondrial function, as well as in mitochondria-related diseases, is largely unexplored. This proposal will fill this knowledge gap and will provide mechanistic insight into the role of ALDH1L2 in human diseases.
线粒体叶酸酶Aldh1l2的硫代粒子作用:NADP + + 10型甲基甲基四氢叶酸盐→NADPH + CO2 +四氢叶酸盐,这对于来自氧化氧化氧化物 - 碳纤维组的线粒体NADPH生产可能很重要。小鼠的基因敲除实验会增加氧化应激罕见的神经性疾病或自动谱系的代谢组学分析。缺陷有分散的线粒体,并恢复了脂质液滴的积累。线粒体的nADPH生成叶酸周期。 )假设ALDH1L2在能量产生或米奇氏菌之间的脂肪酸氧化和脂肪酸氧化之间维持了线粒体平衡的生物合成。已经被授予了ALDH1L2的作用,以及与线粒体相关的SES的作用,在很大程度上没有探索。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SERGEY A KRUPENKO其他文献

SERGEY A KRUPENKO的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SERGEY A KRUPENKO', 18)}}的其他基金

Mechanistic and metabolomic underpinnings of ALDH1L1 polymorphisms in the regulation of glycine metabolism
ALDH1L1 多态性调节甘氨酸代谢的机制和代谢组学基础
  • 批准号:
    10297073
  • 财政年份:
    2021
  • 资助金额:
    $ 47.58万
  • 项目类别:
Mechanistic and metabolomic underpinnings of ALDH1L1 polymorphisms in the regulation of glycine metabolism
ALDH1L1 多态性调节甘氨酸代谢的机制和代谢组学基础
  • 批准号:
    10870688
  • 财政年份:
    2021
  • 资助金额:
    $ 47.58万
  • 项目类别:
Mechanistic and metabolomic underpinnings of ALDH1L1 polymorphisms in the regulation of glycine metabolism
ALDH1L1 多态性调节甘氨酸代谢的机制和代谢组学基础
  • 批准号:
    10663183
  • 财政年份:
    2021
  • 资助金额:
    $ 47.58万
  • 项目类别:
Mechanistic and metabolomic underpinnings of ALDH1L1 polymorphisms in the regulation of glycine metabolism
ALDH1L1 多态性调节甘氨酸代谢的机制和代谢组学基础
  • 批准号:
    10453683
  • 财政年份:
    2021
  • 资助金额:
    $ 47.58万
  • 项目类别:
Regulation of mitochondrial function by folate enzyme ALDH1L2 in health and disease
叶酸酶 ALDH1L2 在健康和疾病中对线粒体功能的调节
  • 批准号:
    10597021
  • 财政年份:
    2019
  • 资助金额:
    $ 47.58万
  • 项目类别:
Regulation of mitochondrial function by folate enzyme ALDH1L2 in health and disease
叶酸酶 ALDH1L2 在健康和疾病中对线粒体功能的调节
  • 批准号:
    10117233
  • 财政年份:
    2019
  • 资助金额:
    $ 47.58万
  • 项目类别:
FDH: A Novel Determinant of Tumor Suppression
FDH:肿瘤抑制的新决定因素
  • 批准号:
    8895055
  • 财政年份:
    2014
  • 资助金额:
    $ 47.58万
  • 项目类别:
Mechanism of action of a major folate enzyme
主要叶酸酶的作用机制
  • 批准号:
    8013378
  • 财政年份:
    2010
  • 资助金额:
    $ 47.58万
  • 项目类别:
FDH: A Novel Determinant of Tumor Suppression
FDH:肿瘤抑制的新决定因素
  • 批准号:
    7017706
  • 财政年份:
    2005
  • 资助金额:
    $ 47.58万
  • 项目类别:
FDH: A Novel Determinant of Tumor Suppression
FDH:肿瘤抑制的新决定因素
  • 批准号:
    7558315
  • 财政年份:
    2005
  • 资助金额:
    $ 47.58万
  • 项目类别:

相似国自然基金

BRD9通过表观重塑促进支链氨基酸代谢介导TP53突变型胰腺癌化疗耐药的机制研究
  • 批准号:
    82360519
  • 批准年份:
    2023
  • 资助金额:
    32 万元
  • 项目类别:
    地区科学基金项目
肠道菌群与高血压严重程度的关联及通过氨基酸代谢调控的作用机制研究
  • 批准号:
    82304211
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
化瘀通络法通过SATB1/JUNB介导“氨基酸代谢网-小胶质细胞极化”调控脑缺血神经功能恢复的机制研究
  • 批准号:
    82374172
  • 批准年份:
    2023
  • 资助金额:
    49 万元
  • 项目类别:
    面上项目
特定肠道菌种在氨基酸调控脂质代谢中的作用与机制研究
  • 批准号:
    82300940
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目
基于MRI影像组学及氨基酸代谢组学的前列腺癌精确诊断和预后预测研究
  • 批准号:
    62303235
  • 批准年份:
    2023
  • 资助金额:
    30 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

Exploring the Role of Nitrogen Metabolism in Cancer
探索氮代谢在癌症中的作用
  • 批准号:
    10737792
  • 财政年份:
    2023
  • 资助金额:
    $ 47.58万
  • 项目类别:
Structurally engineered N-acyl amino acids for the treatment of NASH
用于治疗 NASH 的结构工程 N-酰基氨基酸
  • 批准号:
    10761044
  • 财政年份:
    2023
  • 资助金额:
    $ 47.58万
  • 项目类别:
The regulation of cancer and aging by methionine
蛋氨酸对癌症和衰老的调节
  • 批准号:
    10750559
  • 财政年份:
    2023
  • 资助金额:
    $ 47.58万
  • 项目类别:
Deciphering a novel kinase function for adck2 in the heart
破译心脏中 adck2 的新激酶功能
  • 批准号:
    10664070
  • 财政年份:
    2023
  • 资助金额:
    $ 47.58万
  • 项目类别:
Mechanistic evaluation of resistance to sulfite toxicity in Salmonella
沙门氏菌抗亚硫酸盐毒性的机制评价
  • 批准号:
    10724560
  • 财政年份:
    2023
  • 资助金额:
    $ 47.58万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了